Matthew Buten serves as Executive at Biohaven Pharmaceutical Holding Co Ltd., where they oversee executive responsibilities. Since joining the company, Matthew Buten has executed 13 insider transactions totaling $2.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 5, 2026 involved exercising options for 4,250 shares valued at $0.
Matthew Buten currently holds 8,500 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Buten has been a net buyer of BHVN stock. They have purchased $2.0M and sold $0 worth of shares.
Matthew Buten's most recent insider trade was on Jan 5, 2026, when they sold 4,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $9.93 |
| Discretionary |
| Jan 5, 2026 | BHVN | $0 | Option Exercise | 4,250 | $N/A | Discretionary |
| Oct 5, 2023 | BHVN | $500.0K | Purchase | 22,727 | $22.00 | Discretionary |
| Oct 25, 2022 | BHVN | $1.5M | Purchase | 142,857 | $10.50 | Discretionary |
| Oct 3, 2022 | BHVN | $917.3K | Disposition | 6,177 | $148.50 | Discretionary |
| Oct 3, 2022 | BHVN | $0 | Other | 18,750 | $N/A | Discretionary |
| Oct 3, 2022 | BHVN | $9.9K | Option Exercise | 1,550 | $6.37 | Discretionary |
| Oct 3, 2022 | BHVN | $72.9K | Option Exercise | 11,450 | $6.37 | Discretionary |
| Oct 3, 2022 | BHVN | $82.8K | Payment | 11,042 | $7.50 | Discretionary |
| Oct 3, 2022 | BHVN | $0 | Other | 3,088 | $N/A | Discretionary |
| Dec 31, 2021 | BHVN | $871.4K | Payment | 6,323 | $137.81 | Discretionary |
| Dec 31, 2021 | BHVN | $0 | Option Exercise | 12,500 | $N/A | Discretionary |